Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 6
Stanford University, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 7
Stanford University, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 8
Stanford University, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 9
Stanford University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 10
Stanford University, Medical Devices Deals, 2011 to YTD 2017 11
Stanford University, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 12
Stanford University, Pharmaceuticals & Healthcare, Deal Details 15
Venture Financing 15
Arcus Biosciences Raises USD70 Million in Series B Financing 15
Partnerships 16
Takeda Pharma Partners with Stanford University 16
Alligator Bioscience Expands Agreement with Stanford University 17
Vedanta Biosciences Enters into Agreement with Stanford University School of Medicine 18
Stanford University’s School of Medicine and uBiome Enter into Research Agreement 19
Stallergenes Greer Enters into Agreement with Stanford University 20
Cohen Veterans Bioscience Enters into Agreement with Stanford University School of Medicine 21
RedHill Biopharma Enters into Research Agreement with Stanford University School of Medicine 22
twoXAR Enters into Agreement with Stanford University School of Medicine 23
twoXAR Enters into Research Agreement with Stanford University 24
Intermountain Healthcare Enters into Agreement with Stanford Genome Technology Center 25
SRI Biosciences Enters into Agreement with Stanford Cancer Institute 26
ImmunoCellular Therapeutics Enters into Research Agreement with Stanford University 27
SRI Biosciences Enters into Agreement with Stanford Cancer Institute 28
aTyr Pharma Enters into Agreement with Hong Kong University of Science and Technology, Scripps Research Institute and Stanford University for Human Proteins Discovery 29
Activaero Enters Into Research Agreement With Stanford University 30
Benitec Biopharma Enters Into An Agreement With Stanford University 31
Sanofi-aventis Enters Into Research Collaboration With Bio-X Stanford University 32
Licensing Agreements 33
Vir Biotechnology Enters into Licensing Agreement with Stanford University 33
Aldevron Enters into Licensing Agreement with Stanford University 34
Stanford University Enters into Licensing Agreement with Trianni for Trianni Mouse 35
Neurotrope Enters into Licensing Agreement with Stanford University 36
Aduro BioTech Enters into Licensing Agreement with Stanford University 37
Medicenna Therapeutics Enters into Licensing Agreement with Stanford University 38
Renova Therapeutics Enters into Licensing Agreement with Stanford University 39
Mitoconix Bio Enters into Licensing Agreement with Stanford University 40
Abeona Therapeutics Enters into Licensing Agreement with Stanford University 41
Medgenics Enters into Licensing Agreement with Stanford University 42
Eiger BioPharma Enters into Licensing Agreement with Stanford University for Post-Bariatric Surgical Hypoglycemia 43
Eiger BioPharma Enters into Licensing Agreement with Stanford University 44
Eiger BioPharma Enters into Licensing Agreement with Stanford University for Pulmonary Arterial Hypertension 45
Abeona Therapeutics Enters into Licensing Agreement with Stanford University 46
Alexo Therapeutics Receives Rights to SIRPA technology from Stanford University School of Medicine 47
Medeor Therapeutics Enters into Licensing Agreement with Stanford University 48
Neurotrope Enters into Licensing Agreement with Stanford University 49
Forty Seven Enters into Licensing Agreement with Stanford University 50
Horizon Discovery Enters into Licensing Agreement with Stanford University 51
Globavir Enters into Licensing Agreement with Stanford University 52
Sitari Pharma Enters into Licensing Agreement with Stanford University 53
Quest PharmaTech Enters Into Licensing Agreement With Stanford University For Anti-MUC1 IgE Technology 54
Personalis Enters Into Licensing Agreement With Stanford University 55
Atreca Enters Into Licensing Agreement With Stanford University For Immune Repertoire Capture Technology 56
Stem Cell Theranostics Enters into Agreement with Stanford University 57
Transparency Life Sciences Enters Into Option Licensing Agreement With Stanford University 58
Acquisition 59
Stanford Health Care Acquires ValleyCare Health 59
Stanford Hospital Acquires CareCounsel Health Advocacy Specialist 60
Stanford University – Key Competitors 61
Stanford University – Key Employees 62
Stanford University – Locations And Subsidiaries 63
Head Office 63
Other Locations & Subsidiaries 63
Recent Developments 64
Government and Public Interest 64
Sep 19, 2017: CPRIT awards $34M to UTSW for cancer research recruitment 64
Aug 17, 2017: New Way To Empower The Immune System To Detect And Kill Cancer 66
Dec 01, 2016: Portions of the brain fall asleep and wake back up all the time, Stanford researchers find 67
Sep 22, 2016: Kenneth Rainin Foundation Awards Over $3 Million to High-Risk, High Reward Inflammatory Bowel Disease Research Projects 69
May 06, 2016: New treatment for children with ARDS 71
Apr 28, 2016: DNAnexus Cloud Genomics Platform Now Supports Data Management and Genomic Analysis for Leading Genome Research Center 72
Apr 07, 2016: Helmsley Charitable Trust Awards $2.1 Million to Penn, Stanford and Seattle Children’s Research Institute to Explore Cell-Based Therapies for Type 1 Diabetes 73
Appendix 74
Methodology 74
About GlobalData 74
Contact Us 74
Disclaimer 74
Stanford University, Pharmaceuticals & Healthcare, Key Facts 2
Stanford University, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 7
Stanford University, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 8
Stanford University, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 9
Stanford University, Deals By Therapy Area, 2011 to YTD 2017 10
Stanford University, Medical Devices Deals, 2011 to YTD 2017 11
Stanford University, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 12
Arcus Biosciences Raises USD70 Million in Series B Financing 15
Takeda Pharma Partners with Stanford University 16
Alligator Bioscience Expands Agreement with Stanford University 17
Vedanta Biosciences Enters into Agreement with Stanford University School of Medicine 18
Stanford University's School of Medicine and uBiome Enter into Research Agreement 19
Stallergenes Greer Enters into Agreement with Stanford University 20
Cohen Veterans Bioscience Enters into Agreement with Stanford University School of Medicine 21
RedHill Biopharma Enters into Research Agreement with Stanford University School of Medicine 22
twoXAR Enters into Agreement with Stanford University School of Medicine 23
twoXAR Enters into Research Agreement with Stanford University 24
Intermountain Healthcare Enters into Agreement with Stanford Genome Technology Center 25
SRI Biosciences Enters into Agreement with Stanford Cancer Institute 26
ImmunoCellular Therapeutics Enters into Research Agreement with Stanford University 27
SRI Biosciences Enters into Agreement with Stanford Cancer Institute 28
aTyr Pharma Enters into Agreement with Hong Kong University of Science and Technology, Scripps Research Institute and Stanford University for Human Proteins Discovery 29
Activaero Enters Into Research Agreement With Stanford University 30
Benitec Biopharma Enters Into An Agreement With Stanford University 31
Sanofi-aventis Enters Into Research Collaboration With Bio-X Stanford University 32
Vir Biotechnology Enters into Licensing Agreement with Stanford University 33
Aldevron Enters into Licensing Agreement with Stanford University 34
Stanford University Enters into Licensing Agreement with Trianni for Trianni Mouse 35
Neurotrope Enters into Licensing Agreement with Stanford University 36
Aduro BioTech Enters into Licensing Agreement with Stanford University 37
Medicenna Therapeutics Enters into Licensing Agreement with Stanford University 38
Renova Therapeutics Enters into Licensing Agreement with Stanford University 39
Mitoconix Bio Enters into Licensing Agreement with Stanford University 40
Abeona Therapeutics Enters into Licensing Agreement with Stanford University 41
Medgenics Enters into Licensing Agreement with Stanford University 42
Eiger BioPharma Enters into Licensing Agreement with Stanford University for Post-Bariatric Surgical Hypoglycemia 43
Eiger BioPharma Enters into Licensing Agreement with Stanford University 44
Eiger BioPharma Enters into Licensing Agreement with Stanford University for Pulmonary Arterial Hypertension 45
Abeona Therapeutics Enters into Licensing Agreement with Stanford University 46
Alexo Therapeutics Receives Rights to SIRPA technology from Stanford University School of Medicine 47
Medeor Therapeutics Enters into Licensing Agreement with Stanford University 48
Neurotrope Enters into Licensing Agreement with Stanford University 49
Forty Seven Enters into Licensing Agreement with Stanford University 50
Horizon Discovery Enters into Licensing Agreement with Stanford University 51
Globavir Enters into Licensing Agreement with Stanford University 52
Sitari Pharma Enters into Licensing Agreement with Stanford University 53
Quest PharmaTech Enters Into Licensing Agreement With Stanford University For Anti-MUC1 IgE Technology 54
Personalis Enters Into Licensing Agreement With Stanford University 55
Atreca Enters Into Licensing Agreement With Stanford University For Immune Repertoire Capture Technology 56
Stem Cell Theranostics Enters into Agreement with Stanford University 57
Transparency Life Sciences Enters Into Option Licensing Agreement With Stanford University 58
Stanford Health Care Acquires ValleyCare Health 59
Stanford Hospital Acquires CareCounsel Health Advocacy Specialist 60
Stanford University, Key Competitors 61
Stanford University, Key Employees 62
Stanford University, Subsidiaries 63
